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Abstract The diversity of neurons in sympathetic ganglia
and dorsal root ganglia (DRG) provides intriguing systems
for the analysis of neuronal differentiation. Cell surface
receptors for the GDNF family ligands (GFLs) glial cell-
line-derived neurotrophic factor (GDNF), neurturin and
artemin, are expressed in subpopulations of these neurons
prompting the question regarding their involvement in
neuronal subtype specification. Mutational analysis in mice
has demonstrated the requirement for GFL signalling during
embryonic development of cholinergic sympathetic neurons
as shown by the loss of expression from the cholinergic
gene locus in ganglia from mice deficient for ret, the signal
transducing subunit of the GFL receptor complex. Analysis
in mutant animals and transgenic mice overexpressing GFLs
demonstrates an effect on sensitivity to thermal and
mechanical stimuli in DRG neurons correlating at least
partially with the altered expression of transient receptor
potential ion channels and acid-sensitive cation channels.
Persistence of targeted cells in mutant ganglia suggests that
the alterations are caused by differentiation effects and not
by cell loss. Because of the massive effect of GFLs on
neurite outgrowth, it remains to be determined whether GFL
signalling acts directly on neuronal specification or indi-
rectly via altered target innervation and access to other
growth factors. The data show that GFL signalling is
required for the specification of subpopulations of sensory
and autonomic neurons. In order to comprehend this process
fully, the role of individual GFLs, the transduction of the
GFL signals, and the interplay of GFL signalling with other





ASIC acid-sensitive ion channel
Bax bcl-2 associated pro-apoptotic protein
ChAT choline acetyltransferase
CGRP calcitonin gene-related peptide
DBH dopamine beta-hydroxylase
DRG dorsal root ganglion
E embryonic day
EGFP enhanced green fluorescent protein
GDNF glial cell-line-derived neurotrophic factor
GFL GDNF family ligand
GFP green fluorescent protein
GFRalpha GFL receptor alpha subunit
HTMR high-threshold mechanoreceptor
IB4 Griffonia simplicifolia isolectin B4
IHC immunohistochemistry
IR immunoreactivity
ISH in situ hybridization
LTMR low-threshold mechanoreceptor
NGF nerve growth factor
P postnatal day
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Introduction
The differentiationofthe diverse classesofneurons fromtheir
precursor cells is orchestrated by a range of intrinsic and
extrinsic regulators that are becoming increasingly well
characterized. Candidate extrinsic effectors encompass a
multitude of peptide growth factors with nerve growth factor
(NGF) as the prototypic neurotrophic factor. The related
factors of the neurotrophin family and their high-affinity cell
surface receptors trkA (tyrosine kinase receptor, high-affinity
neurotrophin receptor A), trkB and trkC (Fig. 1)w e r ec h a r -
acterized starting in the 1980s; this work has demonstrated in
particular their survival-promoting activity (for a review, see
Snider 1994). In the 1990s, GDNF family ligands (GFLs)
were found by using similar neuron survival assays. Cloning
of the genes coding for glial cell-line-derived neurotrophic
factor (GDNF), neurturin, artemin and persephin and their
cell surface receptors GFRalpha1 to GFRalpha4 acting in a
complex with the receptor tyrosine kinase ret (“rearranged
during transfection” proto-oncogene; for a review, see
Airaksinen and Saarma 2002;F i g .1) has allowed the anal-
ysis of their in vivo function in mutant mice. Surprisingly,
mutant analysis in the peripheral sensory and sympathetic
nervous system shows that GFL signalling does not play a
prominent role in supporting neuronal survival. Instead,
neurite outgrowth and differentiation are major targets of
these signalling pathways. Here, I will review the data
available regarding the role of GFLs in the development of
neurons in sympathetic ganglia and dorsal root ganglia
(DRG), two of the most studied model populations for
neuronal differentiation.
The neurons of sympathetic ganglia and DRG are both
derived from the neural crest (LeDouarin and Kalcheim
1999). In an early segregation event, the autonomic and
sensory lineages diverge. Within these lineages, a subsequent
diversification process that lasts from the time of ganglion
formation well into postnatal development leads to the gene-
ration of an array of specialized neurons suited to subserve
distinct functions.
Diversity of neuronal properties is apparent in the phy-
siological and neurochemical domain. Sympathetic neurons
innervating distinct target tissues such as blood vessels or
Fig. 1 Cell surface receptors for GDNF family ligands and neuro-
trophins in the peripheral nervous system. a The GDNF family ligands,
viz. glial cell-line-derived neurotrophic factor (GDNF), neurturin
(NRTN)a n da r t e m i n( ARTN), bind to the alpha receptor subunits
GFRalpha1, GFRalpha2 and GFRalpha3, respectively. GFRalphas are
linked to the membrane via glycosyl phosphatidylinositol anchors.
Signal transduction occurs by interaction with the transmembrane
receptor ret (c-ret). The intracellular tyrosine kinase domain of ret is
indicated by grey shading. GFRalpha4, which binds persephin, is not
found in sympathetic ganglia and dorsal root ganglia (DRG). Modified
from Airaksinen and Saarma (2002). b The neurotrophins, viz. nerve
growth factor (NGF), brain-derived neurotrophic factor (BDNF)a n d
neurotrophin 3 (NT3) bind with high affinity to the tyrosine kinase
receptors trkA, trkB and trkC, respectively. NT3 may also act via trkA.
p75 is a low affinity neurotrophin receptor
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tivity and neurotransmitter phenotype (for reviews, see Jänig
and McLachlan 1992; Ernsberger 2001). DRG neurons con-
ducting different qualities of afferent information differ in
receptive properties, ion channel equipment, central and
peripheral projection patterns and neuropeptide phenotype
(for reviews, see Burgess and Perl 1973;B r o w n1981;
Schultzberg 1983).
Because of the availability of histochemical methods to
detect catecholamines including noradrenaline, the main
transmitter of sympathetic neurons, the development of
sympathetic neurotransmitter properties became an early
focus of research into neuronal development. With the
establishment of reliable methods to analyse the expression
of mRNA and protein for transmitter-synthesizing enzymes,
the development of noradrenergic and of cholinergic proper-
ties in sympathetic neurons could be studied at the level of
gene expression (for reviews, see Ernsberger and Rohrer
1996, 1999; Ernsberger 2000, 2001). Of particular interest as
markers for the noradrenergic and cholinergic transmitter
phenotype are the enzymes of noradrenaline biosynhesis,
tyrosine hydroxylase (TH) and dopamine β-hydroxylase
(DBH), and the enzyme synthesizing acetylcholine, choline
acetyltransferase (ChAT), which is coexpressed from the
cholinergic gene locus with the vesicular acetylcholine
transporter (VAChT). The lack of ChAT and VAChT ex-
pression in sympathetic ganglia of mice mutant for ret, the
signal transducing subunit of the GFL receptor complex,
demonstrates the role of GFL signalling in cholinergic devel-
opment (Burau et al. 2004).
For afferent neurons in the DRG, the marked specificity in
response to diverse mechanical, thermal and chemical stimuli
detected in electrophysiological single-unit recordings pro-
vokes the question regarding the molecular apparatus under-
lyingthisspecifictransductionprocess andthe developmental
regulation of its assembly. With the recent characterization of
proteins involved in the transduction process of mechanical,
thermal and chemical stimuli, such as proteins from the
transientreceptorpotential(TRP)channelfamily(forreviews,
see Jordt et al. 2003;K o l t z e n b u r g2004; Lumpkin and
Caterina 2007), and the analysis of their expression during
DRG neuron development (Hjerling-Leffler et al. 2007;E l g
et al. 2007), molecular analysis of DRG neuron specification
comes within reach. The effect of ret gene mutation on TRP
channel expression (Luo et al. 2007) demonstrates the
importance of GFLs for sensory neuron specification.
Here I discuss studies of transgenic GFL overexpression
and studies from mouse mutants. The mutant analysis
compares knockout mice for the GFLs GDNF, neurturin
and artemin, their preferred alpha receptor subunits GFRal-
pha1, GFRalpha2 and GFRalpha3, respectively, and the
common signal transducing subunit ret (Airaksinen and
Saarma 2002).
Developmental expression of genes specifying
neuronal diversity
ret and GFRalpha subunits
ret and GFRalpha expression patterns
in sympathetic ganglia
The expression of mRNAs for GFRalpha1, GFRalpha2,
GFRalpha3 and ret is dynamically regulated in mouse sym-
pathetic ganglia during embryogenesis (Nishino et al. 1999;
Enomoto et al. 2001). Expression of a tau-EGFP (enhanced
green fluorescent protein)-myc (TGM) reporter from the ret
locus indicates that at embryonic day 11.5 (E11.5) all pre-
cursors in the superior cervical ganglion (SCG) and stellate
ganglion (STG) express ret (Enomoto et al. 2001). Most cells
lose ret expression by E15.5 and only a subpopulation of
sympathetic cells expresses ret at postnatal day 0 (P0). The
downregulation shown with the reporter construct is con-
firmed by ret immunohistochemistry (IHC; Enomoto et al.
2001). In situ hybridization (ISH) shows widespread expres-
sion in sympathetic ganglia at E13 and expression in neuron
subpopulations at various labelling intensities at P0 (Fig. 2).
GFRalpha1 mRNA as analysed by ISH is detectable at
E12.5, gradually decreases thereafter and is undetectable at P5
(Nishinoetal.1999). mRNAs for GFRalpha2 and GFRalpha3
are expressed in most SCG cells at E12.5 and subsequently
become restricted to smaller subpopulations. At P5, 20%–
30% of SCG cells express GFRalpha3. At P60, GFRalpha3
expression is undetectable by ISH (Nishino et al. 1999).
GFRalpha2 yields strong signals by ISH at P0, whereas
GFRalpha3 gives moderate signals (Fig. 3).
ret and GFRalpha expression in DRG
ret-positive cells develop largely but not exclusively from
trkA-positive cells In adult rats, 59%–64% of lumbar DRG
neurons express ret mRNA as detected by ISH (Bennett et al.
1998, 2000; Kashiba et al. 1998, 2003) and 72% are found
positive for ret protein by IHC (Bennett et al. 1998). In mice,
percentages of cells expressing ret mRNA as determined by
ISH range from 40% (Zwick et al. 2002)t o6 0 % ,c o r r e -
sponding to62% immunopositive cells (Molliver et al. 1997).
During mouse development, a small subpopulation of ret-
positive cells is detectable at E11.5. The early ret-positive
cells do not express trkC (Kramer et al. 2006) or trkA (Luo
et al. 2007), as analysed by double IHC and double ISH,
respectively. At E12, however, 80% of the ret-immunore-
active neurons express trkB (Kramer et al. 2006). By E14.5,
only a few ret-positive cells coexpress any trk receptor.
At E15, ~10% of lumbar DRG neurons express ret
(Molliver et al. 1997) and, at E16, 24% (Baudet et al. 2000).
Whereas the early trkA-negative ret-positive cells have a large
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at later stages. Many trkA-positive neurons coexpress ret at
E16 and these are small to medium in size (Luo et al. 2007).
In newborn animals, ret expression has been detected in 45%
of neurons (Molliver et al. 1997;B a u d e te ta l .2000; compare
Fig. 2) and, at P7.5, the adult pattern is established, with ret
b e i n ge x p r e s s e di ns m a l l -a n dl a r g e - d i a m e t e rn e u r o n s .
Fig. 2 Expression of ret mRNA in sympathetic ganglia and DRG. In
situ hybridization for ret mRNA on trunk cross sections from a 13-
day-old mouse embryo (E13, a) and a newborn animal (P0, b). At
E13, a population of large DRG (asterisks) neurons is positive,
whereas many DRG cells are devoid of signal. Staining is found
throughout the sympathetic ganglia (open arrowheads) albeit at
various intensities. In newborn DRG, a small population of large
neurons is strongly positive, whereas many small cells show weak
signal. In sympathetic ganglia, a subset of cells is ret-positive at
varying signal intensities. Bar 70 μm
Fig. 3 Expression of mRNAs for GFRalpha2 and GFRalpha3 in
sympathetic ganglia and DRG of a newborn mouse. In situ
hybridization for GFRalpha2 mRNA (GFRα2, a) and GFRalpha3
mRNA (GFRα3, b) shows strong GFRalpha2 expression in the
majority of neurons in a sympathetic ganglion (open arrowhead)
and a DRG (asterisk). Strong GFRalpha3 expression is detectable in a
population of DRG neurons. Weak GFRalpha3 labelling is found in
some DRG and many sympathetic ganglion neurons. Bar 70 μm
b
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postnataly and bind the lectin, Griffonia simplicifolia
isolectin B4 Postnatally, neurons coexpressing ret and trkA,
as analysed by double ISH, undergo trkA extinction, which
appears to be complete at P14 (Luo et al. 2007). This process
is ret-dependent as it is slowed down in ret mutants. Con-
versely, ret expression is NGF-dependent as, in NGF/Bax
(bcl-2 associated pro-apoptotic protein) double-mutants, only
a few ret-positive neurons are present at P0 and these are
trkA-negative (Luo et al. 2007).
Inmatureanimals,the overlapofret andtrkAexpressionis
limitedandamountsto~5%–15%inmouselumbarsegment5
(L5) DRG (Molliver et al. 1997;O r o z c oe ta l .2001). In adult
rat, 26%–28% of trkA-positive cells in lumbar DRG express
ret and 15% of ret-positive cells express trkA (Bennett et al.
1998; Kashiba et al. 1998, 2003). A total of 9% of DRG
neurons express both. Approximately half of trkB- and trkC-
positive cells express ret (Kashiba et al. 2003). About 30%
of ret-immunoreactive cells are calcitonin gene-related
peptide (CGRP)-positive (Bennett et al. 1998).
Massive overlap is found between ret expression and
binding of the lectin Griffonia simplicifolia isolectin B4
(IB4). In lumbar DRG of adult rat and mouse, 95% and
100%, respectively, of IB4-binding cells are ret-positive
(Bennett et al. 1998;M o l l i v e re ta l .1997) and ~80% and
~70% of ret-positive cells bind IB4, respectively (Bennett et
al. 1998; Kashiba et al. 2001;M o l l i v e re ta l .1997). IB4-
binding neurons constitute a population of functionally dis-
tinct nociceptors that differ in the duration of action potentials
(Stuckyand Lewin1999;F a n ge ta l .2006), amplitude of heat-
activated currents, density of tetrodotoxin (TTX)-resistent
sodium currents (Stucky and Lewin 1999)a n di m m u n o r e a c -
tivity (IR) for the sodium channel Nav1.9 (Fang et al. 2006).
Because ofthe limited colocalization of IB4 binding and CGRP
expression (Silverman and Kruger 1990), peptidergic and non-
peptidergic nociceptors have been distinguished and are
correlated with trkA and ret expression, respectively. How-
ever, of note, not all IB4-binding cells are nociceptors (Fang
met al. 2006), some trkA-positive cells bind IB4 and some ret-
positive cells show no IB4 binding (Kashiba et al. 2001).
There is a large but incomplete overlap of ret and GFRalpha
expression ret expression overlaps largely with expression of
GFRalpha1,GFRalpha2andGFRalpha3.Ofret-positivelum-
bar DRG neurons, 66% express GFRalpha1 in adult rat
(Kashiba et al. 2003) and 89% in adult mice (Molliver et al.
1997), as analysed by ISH on serial sections and double ISH,
respectively. In P14 mice, 18% of ret-positive cells express
GFRalpha1 as analysed by double ISH (Luo et al. 2007).
Some 34% of ret-positive cells express GFRalpha2 and 33%
express GFRalpha3 in the lumbar DRG of adult rat (Kashiba
et al. 2003). In P14 mice, 61% and 14% of ret-positive cells
express GFRalpha2 and GFRalpha3, respectively (Luo et al.
2007). Conversely, 79% of GFRalpha1-positive cells express
ret (Kashiba et al. 2003) and more than 90% of GFRalpha2-
and GFRalpha3-expressing cells are ret-positive in adult rats
(Kashiba et al. 1998, 2003;O r o z c oe ta l .2001). In adult
mice, 82% of GFRalpha3-positive cells express ret, as
analysed by double IHC (Orozco et al. 2001). Data on the
coexpression of GFRalpha receptors differ between studies
(Bennett et al. 1998; Kashiba et al. 2003).
Expression of GFRalpha1 and GFRalpha2, but not
GFRalpha3, depends on NGF, as shown in newborn NGF/
Bax double-mutant mice where GFRalpha1 is undetectable
and GFRalpha2 expression is strongly reduced (Luo et al.
2007). Polymerase chain reaction on template synthesized by
reverse transcription (RT-PCR) in sensory neuron cultures
indicates that this may be a direct effect of NGF on neuronal
mRNA levels. In addition, GFRalpha1- and GFRalpha2-
expressing cells are reduced at P2 and P10 in ret mutants by
60% and 25%, respectively (Luo et al. 2007).
The results suggest that NGF signalling controls the initial
expression of GFRalpha1 and GFRalpha2, whereas ret
autoregulates their levels at later stages. Signals regulating
GFRalpha3 expression remain to be determined.
GFRalphas are expressed in relatively large DRG neuron
subpopulations Overall, the proportion of GFRalpha1-posi-
tive cells among DRG neurons is 40%–50% at lumbar levels
in adult rats (Bennett et al. 1998, 2000; Kashiba et al. 1998,
2003) and 20% at thoracic levels in adult humans (Josephson
et al. 2001), as analysed by ISH (Table 1). GFRalpha2-
positive neurons constitute 19%–33% of lumbar DRG neu-
rons in adult rats (Bennett et al. 1998, 2000; Kashiba et al.
2003) and 51% of thoracic DRG neurons in adult humans
(Josephson et al. 2001). GFRalpha3-positive cells make up
Table 1 GFRalpha expression in mammalian DRG. All studies were performed by in situ hybidization (FG fluoro-gold, L lumbar, T thoracic)
Species Stage Level GFRa1 GFRa2 GFRa3 Reference
Mouse Neonatal Lumbar 17 22 34 Baudet et al. 2000
Rat Adult Lumbar 41 33 − Bennett et al 1998
L4/5 42 32 42 Bennett et al. 2000
Retrograde FG labelling from sciatic nerve
L4/5 50 19 17 Kashiba et al. 2003
Human Adult T11/12 20 51 32 Josephson et al. 2001
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42% in adult rat (Bennett et al. 2000;O r o z c oe ta l .2001;
Kashiba et al. 2003) and 32% in adult humans (Josephson et
al. 2001) at lumbar and thoracic levels, respectively.
During mouse development mRNAs for GFRalpha1 and
GFRalpha 2 have been detected by ISH at low levels at E13
and E16 and expression is strongly increased at birth (Baudet
et al. 2000) and for GFRalpha2 after birth (Luo et al. 2007).
In neonatal mice, 17% and 22% of lumbar DRG neurons are
positivefor GFRalpha1and GFRalpha2,respectively(Baudet
et al. 2000). GFRalpha3 mRNA is expressed at low levels at
E13 in most neurons and at high levels at E16 in the
majority of neurons. At birth, high expression levels are
found in 34% of lumbar DRG neurons.
Whereas GFRalpha1-positive cells belong to all size
groups (Bennett et al. 1998; Baudet et al. 2000), the majority
of GFRalpha2- and GFRalpha3-positive cells are of a small
size (Bennett et al. 1998;B a u d e te ta l .2000;O r o z c oe ta l .
2001; Lindfors et al. 2006). In the GFRalpha3-positive
neuron population, 80% and 88% are trkA-positive, 70%
and 97% are CGRP-positive and 94%–99% and 97% are
TRPV1-positive in mouse and rat, respectively (Orozco et al.
2001; Malin et al. 2006). This population does not contain
large-diameter neurons in mice (Baudet et al. 2000). In
contrast, only 1.5% of GFRalpha2-positive neurons in mice
coexpress CGRP (Lindfors et al. 2006) and less than 20% of
GFRalpha2-expressing cells are TRPV1-positive (Malin et
al. 2006;L i n d f o r se ta l .2006). This population contains
preferentially small neurons positive for peripherin, a marker
for unmyelinated neurons as analysed in mice (Lindfors et al.
2006). Moreover, in rat, the vast majority (87%) of DRG
neurons that bind and transport the GFRalpha2 ligand
neurturin are of a small size (Leitner et al. 1999). Only 3%
of the neurturin-labelled cells express trkA.
Thus,GFRalpha3-positive neurons constituteapeptidergic
nociceptor population, which to a large extent coexpresses
trkA and ret. The large majority of GFRalpha2-positive
neurons are small non-peptidergic cells that lack trkA.
Transmitter phenotype in sympathetic ganglia
Mature sympathetic ganglia in birds and mammals contain
twopopulationsofneuronsthatdifferintheirneurotransmitter
phenotype. The majority of neurons synthesizes and releases
noradrenaline, whereas a small subpopulation uses acetylcho-
line (for a review, see Ernsberger and Rohrer 1999). The two
neuron populations differ in their expression of transmitter-
synthesizing enzymes and the vesicular transporters required
for loading transmitter or transmitter precursor into synaptic
vesicles. For both transmitter phenotypes, genes coding for
the characteristic proteins appear to be regulated as synex-
pression groups (for a review, see Ernsberger 2004). mRNAs
for TH and DBH, the rate-limiting and the final enzyme of
noradrenaline biosynthesis, respectively, are induced in
parallel at an early stage (E3) during the formation of pri-
mary sympathetic ganglia in chick (Ernsberger et al. 2000).
In the mouse embryo, TH is detected at E9 (Pattyn et al.
1999). mRNAs for the enzyme of acetylcholine biosynthesis,
ChAT, and the transporter VAChT are detectable later, at E7
in the chick embryo (Ernsberger et al. 1997)a n dE 1 0i nt h e
mouse embryo (Huber and Ernsberger 2006). Initially, the
expression of both sets of genes occurs throughout the sym-
pathetic ganglia in both species and coexpression has been
shown in E7 chick ganglia by IHC and ISH (Ernsberger
et al. 1997). Later, expression of noradrenergic and cholin-
ergic features segregates to distinct neuron populations
(Ernsberger et al. 1997; Burau et al. 2004). An essential
aspect of this process is the loss of ChAT and VAChT ex-
pression in a large number of sympathetic neurons (Burau et
al. 2004). At E18 in chick, when the segregation of norad-
renergic and cholinergic properties to different sympathetic
neuron populations shows in largely non-overlapping pat-
terns of mRNA distribution apparent after ISH (Ernsberger
et al. 1997), trkA expression almost perfectly colocalizes
with the expression of the noradrenaline transporter and
negatively correlates with ChAT (Brodski et al. 2002).
Instead, ChAT expression colocalizes with trkC. In addition,
ret mRNA colocalizes in double ISH with mRNA for the
neuropeptide vasoactive intestinal peptide (VIP), which in
sympathetic ganglia is coexpressed with cholinergic proper-
ties (Ernsberger et al. 2000).
TRP channel expression
Cloning of the capsaicin receptor (VR1/TRPV1) and demon-
stration of its heat sensitivity (Caterina et al. 1997; Tominaga
et al. 1998) has provided a remarkably simple explanation of
aspects of the puzzlingly diverse response spectrum of
polymodal nociceptors. Mutational inactivation of TRPV1
demonstrates its involvement in the detection of noxious
chemical and thermal stimuli by DRG neurons and in the
development of thermal hyperalgesia in an inflammatory
setting (Caterina et al. 2000; Davis et al. 2000; but see
Woodbury et al. 2004). Other members of the family also
respond to elevated temperatures, with TRPV2 being activat-
ed at a remarkably high heat threshold (for a review, see Jordt
et al. 2003). In addition to TRPV1 and V2 as heat sensors,
TRPA1 (Kwan et al. 2006;b u ts e eB a u t i s t ae ta l .2006)a n d
TRPM8 (Bautista et al. 2007; Colburn et al. 2007;D h a k a
et al. 2007) have been reported as cold sensors.
TRPV1, TRPM8 and TRPA1 are expressed preferentially
in small neurons of mature rat DRG (Kobayashi et al. 2005).
Of lumbar DRG neurons, 47% express TRPV1 mRNA or IR
in adult rat (Michael and Priestley 1999;O r o z c oe ta l .2001;
Kobayashi et al. 2005) and 22%–38% show TRPV1 IR in
adult mice (Orozco et al. 2001; Zwick et al. 2002). In adult
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TRPA1 mRNA, respectively (Kobayashi et al. 2005). The
TRPV1-expressing population includes the TRPA1-positive
cells (Kobayashi et al. 2005) but overlap with TRPM8 is
restricted. Of TRPM8 mRNA-positive cells, 30% are
TRPV1-immunoreactive in rat (Okazawa et al. 2004)a n d
no overlap is found in mice (Peier et al. 2002; Dhaka et al.
2008). TRPM8-positive cells in mice have been shown by
EGFP expression from the TRPM8 locus to mark a unique
population of DRG neurons, the majority of which does not
coexpress nociceptive markers (Dhaka et al. 2008).
In adult rat, ~60% of the TRPV1-immunoreactive cells in
L5 DRG show ret IR (Guo et al. 2001). In adult rat and
mouse, 97% and 99% of GFRalpha3-immunoreactive L5
DRG neurons are TRPV1-immunoreactive, respectively, but
~50% of the TRPV1-immunoreactive neurons are not
GFRalpha3-positive (Orozco et al. 2001). TRPV1 expression
and IB4 binding overlap to different degrees in rodents. In
adult rat, 50%–75% of IB4-binding neurons express TRPV1
(Michael and Priestley 1999; Guo et al. 2001; Price and
Flores 2007) and 70%–80% of TRPV1-immunoreactive
cells bind IB4 (Guo et al. 2001; Price and Flores 2007). In
mice, only 2%–6% of IB4-binding neurons in L4/5 DRG
express TRPV1 IR (Zwick et al. 2002; Woodbury et al.
2004;B r e e z ee ta l .2005). No IB4-binding is observed in
TRPM8-expressing DRG neurons in mouse (Peier et al.
2002; Dhaka et al. 2008).
TRPV1, TRPM8 and TRPA1 are coexpressed with trkA,
whereas overlap with the trkB- and trkC-positive population
is minor (<4%) in adult rat (Kobayashi et al. 2005). TRPV1
and TRPA1 expression overlaps partially with trkA in adult
rat DRG. Approximately 45% of the TRPV1- and TRPA1-
positive cells express trkA, whereas 51%–65% (Kobayashi
et al. 2005; MichaelandPriestley1999) and 36% (Kobayashi
et al. 2005) of the trkA-positive cells express TRPV1 and
TRPA1, respectively. Double ISH has shown the expression
of trkA in virtually all TRPM8-positive cells (98%), with
almost half (43%) of trkA-positive neurons expressing
TRPM8.
During mouse development, TRPV1-immunoreactive cells
arefirstdetectedatE13.5inDRGneurons(Tamuraetal.2005).
Capsaicin responses are rarely observed in acutely dissociated
DRG cells from E11.5 DRG with a strong increase in the
proportion of responsive cells between E12.5 (5%) and E14.5
(64%) and a postnatal decline to ~40% (Hjerling-Leffler et al.
2007). TRPM8 is first detected at E16.5 by ISH (Chen et al.
2006). IR is not detected at E15.5 but in few cells at E17.5
(Tamura et al. 2005). This coincides nicely with the onset of
menthol responsiveness in cultures taken from E16.5 mouse
embryos (Hjerling-Leffler et al. 2007).
During rat postnatal development, the proportion of
TRPV1-immunoreactivecellscoexpressingretincreasesfrom
30% atP2to~50%atP10and ~60%atP40(Guoetal. 2001).
The proportion of TRPV1-immunoreactive cells that coex-
presses trkA declines from ~60% at P2 to ~50% at P10
and ~30% at P40. During the same time period, coex-
pression of TRPV1 and substance P (SP) appears unaltered.
TRPV1-immunoreactive cells constitute ~70%–80% of the
SP-immunoreactive population and 30–35% of the TRPV1-
positive cells express SP (Guo et al. 2001). The proportion
of CGRP-immunoreactive cells in mice coexpressing
TRPV1, however, is reported to triple from 20% to 60% of
CGRP-positive cells between P1 and P7 when the percent-
age of TRPV1-immunoreactive cells expressing CGRP
increases from 40% to 60% (Funakoshi et al. 2006). Both
numbers remain stable until P56.
The datasets show that 50%–60% of ret-expressing and
trkA-positiveneuronsexpresstheheatdetectorTRPV1.Inthe
trkA-positive population, TRPM8 expression appears to
segregate to the TRPV1-negative population. In addition,
the observations suggest that the decline in coexpression with
trkA does not coincide with a decline in neuropeptide
coexpression.
Different developmental expression patterns
of population-specific properties
Expression of the genes coding for the proteins discussed in
this review begins at embryonic stages in neurons from
sympathetic ganglia and DRG (Table 2). The pattern of
expression may appear restricted to defined subpopulations
from the onset, as shown for ret in DRG neurons (Figs. 2, 4)
or widespread as observed for ret and cholinergic properties
in sympathetic neurons (Fig. 5). An increase in the pro-
portion of ret-positive cells in the former case (“progressive
increase”) or a restriction in the prevalence of cells ex-
pressing cholinergic properties in the other situation (“pro-
gressive restriction”) results in the subpopulation-restricted
expression of the respective characters observed at birth.
Postnataly, population sizes may be altered to increase, such
as the cholinergic neurons in sympathetic ganglia, or to
decrease, such as the trkA-positive neurons in DRG.
Functional analysis of GFL signalling
in the sympathetic system
Alterations in the peripheral sympathetic system of mice
mutant for GFLs and their receptor subunits
Newborn mice lacking GDNF show a 35%–40% reduction of
neuron number in the SCG (Moore et al. 1996). In addition,
soma size is reduced. In contrast, for mutants of the GDNF
receptor alpha subunit, GFRalpha1, the neuron number (88%
of wildtype) is not affected significantly (Enomoto et al.
1998). Moreover, soma cross sections are similar between
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mice, neuron profile counts (105% of wildtype) and gang-
lion volume are not statistically different from wildtype
(Heuckeroth et al. 1999). Likewise, in mutants of the
neuturin receptor alpha subunit, GFRalpha2, no significant
difference in SCG neuron number is detected as compared
with adult wildtype animals (Rossi et al. 1999). Correspond-
ingly, apoptosis as detected by activated caspase 3 is not
increased in mutant ganglia at E15–P0 (Lähteenmaki et al.
2007). However, the soma size of VIP-immunoreactive
neurons but not of TH-positive cells is reduced in GFRal-
pha2 mutant mice (Hiltunen and Airaksinen 2004). In mice
mutant for the artemin receptor subunit GFRalpha3, 40%–
50% cell loss is observed around birth (Nishino et al. 1999).
The data suggest that GFL signalling through GFRalpha
receptors affects sympathetic neuron subpopulations and
show a prominent survival effect only for GFRalpha3, and
notfor GFRalpha1andGFRalpha2.Thediscrepancybetween
the effects of GDNF and its coreceptor GFRalpha1 may be
attributable to alternative GDNF signalling pathways and
warrants more detailed analysis.
Mutational inactivation of the ret gene affects sympathetic
ganglion cell number in a complex manner by altering
precursor migration, proliferation and cell survival
Mutant strains for ret have been generated by removing the
tyrosine kinase domain (Schuchardt et al. 1994)a n d ,
alternatively, by replacing the first exon with a TGM
reporter (Enomoto et al. 2001). Whereas initial reports from
the kinase-deficient strain claimed a loss of the SCG but not
of other sympathetic ganglia (Durbec et al. 1996), analysis of
the TGM strain showed caudal displacement and a size
reduction of the SCG in newborn animals (Enomoto et al.
2001). Even at E11.5, SCG primordia show a decrease in
cell number by ~30%. Moreover, thoracic and lumbar sym-
pathetic ganglia, including the STG, are reduced in size in
newborn mutant mice (Enomoto et al. 2001). This has been
confirmed for kinase-deficient mice in which the cell number
in the STG is reduced by 24% in newborn animals and by
42% at E16 (Burau et al. 2004). The data show that
Fig. 4 ret expression in sympathetic ganglia (SYG) and dorsal root
ganglia (DRG) during mouse embryogenesis. ret is detected in SYG and
DRG during embryonic day 11. Whereas expression in DRG is initally
restricted to few neurons of large diameter, expression in SYG is found at
this stage throughout the ganglion. During the third week of embryonic
development, an increasing number of small neurons in DRG initiates ret
expression, while expression in sympathetic ganglia is restricted to a
subset of neurons thus distinguishing a “progressive increase” from a
“progressive restriction” of gene expression to neuron subpopulations
(arrow NGF requirement for the increase in the ret-positive population in
DRG)
Table 2 Onset of expression of receptors and function-specific
markers during mouse embryogenesis (see text for references).
Expression analysed by in situ hybridization (ISH), immunohisto-
chemistry (IHC) or detection of GFP expression from gene locus
(GFP)























<Onset not precisely known; positive cells found at times indicated
aPostnatal increase in population size
bInitially widely expressed; embryonic downregulation to neuronal
subpopulation
cAfter initial expression, completely downregulated during embryo-
360 Cell Tissue Res (2008) 333:353–371sympathetic ganglion cell number in ret mutant mice is
affected even at early embryonic stages and from cervical to
lumbar levels.
TheincreaseinpyknoticcellsinSCGandSTGofnewborn
animals and at E16.5 in STG shows that celldeath contributes
to neuronal cell loss in ret mutant mice during the third week
of embryonic development to birth (Enomoto et al. 2001).
Surprisingly, the dying cell population (positive for activated
caspase 3) and the ret-positive (TGM-expressing) population
are largely non-overlapping. No selective elimination of the
ret-positive cell population by the ret mutation has been
concluded to occur, which is supported by the similar
proportion of TGM-reporter-expressing cells in heterozygous
and homozygous mutant mice (Enomoto et al. 2001).
No increase in cell death is observed in SCG and STG of
mutant animals at E10.5–E13.5. In addition, the size of the
BrdU-positiveproliferatingpopulationiscomparableatE11.5
between wildtype and mutant mice (Enomoto et al. 2001).
Thus, the reduced cell number in SCG at early developmen-
tal stages seems to be attributable to deficits during the
migration period rather than to alterations in cell survival or
proliferation after ganglion formation. At E16.5, however,
cell proliferation is found in SCG and STG of ret mutants
but not wildtype animals (Enomoto et al. 2001)i n d i c a t i n g
an extended proliferation period in mutant animals. Together
withtheobservationofneuroblast-likemorphology(Enomoto
et al. 2001) and reduced cell size (Burau et al. 2004)a t
E16.5, the finding suggests a delayed differentiation in mu-
tants. The prolonged proliferation period may account for the
decrease in the relative loss of STG cells from E16.5 to P0
(see above).
Taken together, a complex set of alterations accounts for
the decreased sympathetic neuron number in ret mutant mice.
A migration-related deficit leads to reduced cell numbers in
the newly formed SCG during the second embryonic week.
No alteration in apoptosis and proliferation is detected at this
stage but is found at later stages. Increased proliferation and
cell death occurs in the STG during the third week of em-
bryonic development.
GFRalpha3 mutants show altered SCG position
and cell number attributable to migration, proliferation
and survival effects
Sympathetic development has been analysed in detail in three
strains of GFRalpha3 mutant mice. The first has exons 4–
8 removed (Nishino et al. 1999), whereas in the second, tau-
lacZ is introduced in exon 1 (Honma et al. 2002)a n d ,i nt h e
third strain, exon 1 is replaced by a PGK1-neo cassette
(Andres et al. 2001). In all strains, homozygous animals
show a size reduction and caudal shift of the SCG at E12.5
(Nishino et al. 1999) and E14.5 (Andres et al. 2001)a n di n
adult animals (Honma et al. 2002). In addition, thoracic
ganglia are invariably smaller and aberrantly segmented, as
analysed in adult and newborn GFRalpha3 and artemin
mutant animals (Honma et al. 2002).
Inbothtypes ofmutants,ptosisisreportedtocorrelate with
the size reduction or loss of the SCG. In the tau-lacZ [exon1]
animals, ptosis is observed in 30% of adult homozygous
mutants (Honma et al. 2002). Identical percentages of
animals with uni- or bilateral ptosis are reported for mice
with a mutation in the gene coding for the GFRalpha3 ligand
Fig. 5 Cholineric differentiation of sympathetic neurons during
mouse embryogenesis. Initiation of cholinergic differentiation occurs
during embryonic day 11 when ChAT and VAChT mRNA is first
detectable by in situ hybridization. The majority of neurons rapidly
become positive for the cholinergic markers. After embryonic day 14,
most cells lose ChAT and VAChT expression. A small percentage of
neurons remains positive at birth; this depends on ret tyrosine kinase
activity. After birth, gp130 signalling is required for the postnatal
increase in the number of cholinergic cells (arrow period of ret
dependence, dotted lines onset of ret and gp130 dependence, which
are not precisely determined). Percentage of positive cells is given as
relative values
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eye showing ptosis is missing (30%) or reduced in size
(70%). In adult animals without ptosis, SCG show normal
cell numbers (Honma et al. 2002). For the [exon 4–8]
removal mutants, more dramatic effects on the SCG are
reported: the cell number at P60 is only 0%–5% of that in
wildtype (Nishino et al. 1999).
In [exon 4–8] removal mutants, cell numbers have been
quantified during development (Nishino et al. 1999). Al-
though no difference in SCG cell number is reported at
E11.5, E12.5 mutants have 70%, E14.5 60% and P7 50% of
the wildtype cell number. TUNEL staining at P5 indicates
the involvement of cell death at least postnatally. For STG,
the mutant cell number is reported to be higher than that in
wildtype at E12.5 (140%) and no different from wildtype at
E14.5 (Nishino et al. 1999). The reduced number of SCG
neurons during embryonic development has been confirmed
at E14 in the PGK-neo [exon1] mouse (Andres et al. 2001).
In this mutant, evidence for a reduction in neuroblast
proliferation has been provided. IHC for the proliferation
marker proliferating nuclear cell antigen (PCNA) shows a
reduction of ~50% of PCNA-immunoreactive βIII-tubulin-
positive cells at E14. These studies indicate that the
reduction in SCG cell numbers is attributable to altered
proliferation during embryogenesis and cell death postnatal-
ly. The difference between cell number in SCG and STG at
E14.5 suggests additional effects of the GFRalpha3 mutation
on cell migration.
Quantification in the tau-lacZ [exon1] mutants differs in
some detail (Honma et al. 2002). At E10.5, sympathetic
precursors adjacent to the dorsal aorta at forelimb levels are
reduced by ~20% relative to wildtype animals. At E12.5
neuroblast numbers in the SCG of mutant animals are ~90%
of wildtype (Honma et al. 2002). No increased apoptosis has
been reported during embryogenesis. At P0, increased apop-
tosis is found in SCG of artemin mutant mice when the
position of the ganglion is shifted, but not in normally posi-
tioned ganglia. BrdUlabelling provides no evidence foreffects
on proliferation at E11.5–E14.5 in the GFRalpha3 [exon 4–8]
removal mutants or the artemin mutants (Honma et al. 2002).
This second data set suggests that early embryonic SCG
development is affected by GFRalpha3 effects on cell mi-
gration rather than survival and proliferation.
Mutational analysis shows effects of GFL signalling
on sympathetic target innervation
Severe deficits in sympathetic axonal projections are reported
in ret TGM mice (Enomoto et al. 2001). In newborn mutants,
projections from the SCG via the internal carotid nerve are
attenuated and show abnormal branching. Sympathetic fibres
in rostral facial structures such as the eyes, nasal mucosa and
skin are almost completely depleted. Innervation density in
the submandibular gland of mutant animals never reaches
normal levels. The vertebral nerve as a major trunk projecting
from the STG is also reduced. In addition, sympathetic
projections from prevertebral ganglia such as branches along
the superior mesenteric artery are depleted. Even at E10.5,
fewer sympathetic cells extend long neurites in mutant mice
as compared with wildtype animals (Enomoto et al. 2001).
Impaired axonal projections become more obvious in the
SCG, STG and prevertebral ganglia at E12.5-E13.5. At
E15.5, rostral projections from the SCG to form the internal
carotid nerve are thin. In two out of four animals, nerve
bundles project in the wrong direction.
In GFRalpha3 [exon 4–8] removal mutants, TH-positive
fibres are lost in the submandibular gland and the superior
tarsus muscle of adult animals and at P1 (Nishino et al. 1999).
In the tau-lacZ [exon1] mutants, abnormal innervation of the
superior tarsus muscle is observed only in animals showing
ptosis and abnormal or missing SCG (Honma et al. 2002).
The gut, receiving TH-positive fibres from prevertebral
sympathetic ganglia, shows reduced innervation in mutant
mice with specific loss in circular muscle layers of the oeso-
phagus, stomach and intestine. In these and artemin mutants,
failuretoformnormallyfasciculatedaxonbundlesisreported.
As early as E12.5 and E13.5, axonal outgrowth from the SCG
and prevertebral ganglia is abnormal (Honma et al. 2002).
Interestingly, axonal outgrowth deficits are apparent in all
mutant embryos.
InGDNFmutantmice,THimmunostainingasanindicator
of sympathetic innervation is reduced in blood vessels and
glands in the head (Granholm et al. 1997). In parallel, a clear
reduction of the TH signal is reported in the SCG. In
GFRalpha1 mutant mice, however, the innervation of facial
blood vessels as analysed by TH IHC is equivalent to that of
wildtype animals (Enomoto et al. 1998).
In GFRalpha2 mutant mice, a profound reduction in
innervation density is found in targets of cholinergic, but not
noradrenergic, sympathetic fibres (Hiltunen et al. 2000;
Hiltunen and Airaksinen 2004; Rossi et al. 1999). Immu-
nostaining for VAChT and the neuropeptide VIP has been
used for cholinergic markers, with TH IHC as a noradren-
ergic indicator. The difference in density of cholinergic sweat
gland innervation between wildtype and mutant animals
manifests during postnatal development as analysed at P21
(Hiltunen and Airaksinen 2004). The early innervation
pattern by noradrenergic fibres at P4 shows no difference
from wildtype.
Mutational inactivation of ret leads to an almost complete
loss of cholinergic markers in newborn sympathetic ganglia
In prehatching chick embryos, ret mRNA expression in
paravertebral sympathetic ganglia is highly colocalized with
the cholinergic marker peptide VIP (Ernsberger et al. 1997).
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volved in the development of cholinergic sympathetic
neurons.Analysisoftyrosinekinase-deficientret mutantmice
byISH shows a massive lossofChATandVAChTmRNAs in
sympathetic ganglia (Burau et al. 2004). Compared with
wildtype, the number of positive cells is reduced by more
than 90% in newborn mutant STG. As early as E16,
cholinergic marker expression is affected by the ret mutation.
The number of STG cells with strong expression of ChAT
and VAChT mRNAs is reduced in mutant animals by more
than 80%. Cells showing low levels of expression of VAChT
mRNA at this stage, however, are only moderately reduced
in mutant mice, similar to the total cell population. At E13
and E14, when many STG cells express ChAT and VAChT
mRNAs atlow levels, noreduction ofthe cholinergic markers
is observed by ISH in mutant mice (Burau et al. 2004). The
data show that ret is required for the development of choli-
nergicsympathetic neurons atadvanceddevelopmentalstages
but not for the induction of ChAT and VAChT expression
early during embryonic development. The way in which ret
affects the development of cholinergic neurons still has to be
clarified. Since ret-expressing cells are not preferentially lost
in ret mutant mice (Enomoto et al. 2001) and ret is expressed
in cholinergic cells in chick sympathetic ganglia (Ernsberger
et al. 1997), the loss of ChAT- and VAChT-positive sym-
pathetic cells in ret mutants may be attributable to an altered
regulation of cholinergic gene expression rather than the loss
of cells by cell death. Whether this effect is directly mediated
by ret signalling or indirectly, for example, via axonal out-
growth and access to other growth factors also remains to be
clarified. In explant cultures of sympathetic ganglia from
E12 chick embryos, GDNF and neurturin increase ChAT
mRNA levels as detected by RT-PCR (Brodski et al. 2002).
However, whether this is attributable due to selective
survival or induction of gene expression is unclear.
In GFRalpha2 mutants, where the innervation of two tar-
gets of cholinergic sympathetic neurons, viz. the periosteum
and sweat glands in foot pads, is compromised, the number of
neurons expressing the cholinergic marker peptide VIP is not
significantly altered (111%) compared with wildtype (Hiltunen
and Airaksinen 2004). The data suggest that this mutation
does not affect the expression of a neuropeptide characteristic
for cholinergic sympathetic neurons. Whether ChAT and
VAChT expression is affected remains to be analysed.
Summary of analysis in sympathetic neurons
ret and GFRalpha expression
In sympathetic ganglia of mouse embryos, widespread ret
expression can be detected at E11.5. This expression is
restricted to a subpopulation of sympathetic neurons at birth.
GFRalpha1-3 are detectable at E12.5 but the onset of ex-
pressionisunclear.Withongoingdevelopment,GFRalpha1is
lost from sympathetic neurons, whereas GFRalpha2 and 3 are
restricted to neuron subpopulations.
Sympathetic ganglion cell number
In ret mutant mice, sympathetic ganglion cell number is re-
duced even at E11.5 by 30% as compared with wildtype. This
may be attributable to an effect during precursor migration to
the ganglionic sites. At E16.5, increased apoptosis and
increased proliferation occurs in mutant sympathetic ganglia
demonstrating the complex action of ret signalling on
sympathetic neuron number. In newborn mutant animals,
STG neuron number is 24% smaller than that in wildtype.
In artemin and GFRalpha3 mutant animals, cervical and
thoracic sympathetic ganglia are reduced in size. For
GFRalpha3 mutants, approximately 50% cell loss is reported
for the SCG at birth, with effects on migration, proliferation
and survival being documented. Since cell loss is observed
only when ganglia are displaced and enhanced apoptosis is
detected postnatally and not embryonically, it may occur
secondary to disturbed target innervation and access to target-
derived survival factors. In contrast, neither newborn neur-
turin mutants nor adult GFRalpha2 mutants have revealed
significant changes in sympathetic neuron number. For
GDNF (but not GFRalpha1) mutants, approximately 40%
cell loss is reported.
Thus, mutant analysis shows multiple effects of ret signal-
ling on sympathetic neuron number. The artemin/GFRal-
pha3 pathway and GDNF, but not GFRalpha1 or neurturin/
GFRalpha2, appear involved.
Neurite outgrowth
ret mutants show altered outgrowth of sympathetic neurites
as early as E10.5. Alterations include erroneous direction of
growing neurites indicating effects on pathway choice.
GFRalpha3 also affects neurite outgrowth emphasizing the
importance of this signal transducer for various aspects of
sympathetic development. For GFRalpha2, which has no
major effect on sympathetic neuron number, a reduction of
innervation in targets of cholinergic sympathetic neurons is
found.
Transmitter phenotype
Coexpression of ret with cholinergic properties in chick
sympathetic neurons has suggested the involvement of ret
signallinginthedevelopmentofthisneuronalsubset.Thishas
been confirmed in newborn ret mutant mice, which almost
entirely lose the expression of ChAT and VAChT mRNAs in
sympatheticganglia.ThepersistenceofGFP-positiveneurons
in mutant mice in which the ret coding sequence is replaced
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lost but lack gene expression from the cholinergic locus.
The effect of ret mutation becomes apparent when the
initially widespread expression of the cholinergic markers
becomes restricted to a small subset of cells during the third
week of embryonic development. The observations establish
different stages of transmitter phenotype specification char-
acterized by changing growth factor requirements and
increasing restriction of gene expression patterns. The initial
expression of cholinergic properties in a large proportion of
sympathetic neurons from E10.5 to E14.5 is ret-independent.
The restriction of cholinergic properties to a small subpop-
ulation of neurons that occurs until birth requires ret.
Role of GFLs and their receptors in DRG
neuron development
Analysis of mutant mice
The data available for mice mutant in the GFL or GFRalpha
genes are currently limited. Neonatal GDNF mutant animals
showa 23%–28% reductioninneuronnumbers inL5DRGas
determined with two different counting methods (Moore et al.
1996). Cell area measurements in the mutant animals are
shifted to larger sizes (Baudet et al. 2000) indicating that
small neurons may be lost preferentially. In neonate GFRal-
pha1 mutant animals, however, no cell loss is reported in L5
DRG(Cacalanoetal.1998) and neurons appear histologically
normal (Enomoto et al. 1998). Since the survival effects of
GFLs in cell culture become apparent at postnatal stages
(Baudet et al. 2000), the analysis of mutant mice after birth
seems relevant. Homozygous GDNF and GFRalpha1 mutant
animals, however, die within the first 1.5 days after birth. On
the other hand, mice with homozygous mutations of artemin
or GFRalpha3 survive to adulthood. DRG of adult artemin
mutant mice are of normal size and morphology (Honma et
al. 2002). No deficits are apparent in IB4 binding or CGRP-
immunoreactiveneurons.Similarly,thetotalnumberofneurons
in DRG of GFRalpha3 mutant mice is normal at all stages
analysed (which are not further specified) and the percentage of
CGRP-immunoreactive neurons is unaltered in adult animals
(Nishino et al. 1999). In neurturin mutant mice, the number of
GFRalpha2-positive cells is reduced by 45% in adult L4 DRG
(Heuckeroth et al. 1999). However,whetherthisisattributable
to the loss of neurons or of expression is unclear. In GFRalpha2
mutant mice, DRG appear of normal size (Rossi et al. 1999)
and apoptosis, as determined by activated caspase 3 IHC, is
not significantly different from wildtype DRG at E15–P0
(Lähteenmaki et al. 2007). In the saphenous nerve of these
animals, no loss of myelinated or unmyelinated axons is
observed (Stucky et al. 2002) suggesting that neuron numbers
in GFRalpha2 mutant animals may be unaltered.
ret appears not to be required for cell viability
but for TRPA1 expression
In P14 ret mutant animals, cell counts in L5 DRG sections are
only 15% reduced compared with controls (Luo et al. 2007).
No cell loss is detected after counting the cells of dissociated
ganglia,leadingthe authorstoconcludethatretisnot required
for cell viability. In addition, the proportion of different sen-
sory populations, in particular those expressing CGRP, is
unaltered. Cell size, however, is affected in a population-
specific manner. Peripherin-immunoreactive neurons are
reduced in size, whereas CGRP-positive and neurofilament-
200-immunoreactive cells appear normal, indicating that non-
peptidergic neurons are affected. Peripheral target innervation
is also altered in a population-specific manner. In the skin,
substantial reduction of non-peptidergic fibres is found in the
epidermis, whereas CGRP-positive innervation appears nor-
mal.Incontrast,thelamina-specificdistributionofpeptidergic
and non-peptidergic innervation in the spinal cord appears
unaffected. The expression of TRP channels is selectively
altered in mutant DRG neurons. TRPA1 mRNA expression is
completelyabsentfromP14retmutantDRG,whereasmRNAs
for TRPV1 and TRPM8 appear unaffected. The authors con-
clude that ret controls the expression of a subset of genes
characteristic ofmaturenon-peptidergic nociceptors(Luoet al.
2007).
GFRalpha2 mutation affects cold sensitivity in vivo
and heat sensitivity in vitro
InGFRalpha2mutantmice, axondiameters are reducedinthe
saphenous nerve (Stucky et al. 2002) and IB4-binding DRG
neuron profiles are reduced in size (Lindfors et al. 2006). In
contrast, CGRP-immunoreactive neurons show a normal size
distribution in GFRalpha2 mutants. Correspondingly, the
density of CGRP-positive fibres in mutant epidermis appears
normal, whereas the density of neuron-specific protein gene
product 9.5 (PGP9.5)-positive CGRP-negative fibres is
reduced by ~70%. The subepidermal nerve plexus in footpad
dermis shows unaltered fibre density. The central projection
of IB4-positive fibres to lamina II in the spinal cord appears
normal. Behavioural testing of GFRalpha2 mutant mice
shows normal behaviour to tactile stimulation and to
innocuous temperatures and hot-plate testing. However, in
cold water, withdrawal occurs with much shorter latencies
and formalin-induced persistent pain is reduced in mutants
(Lindfors et al. 2006).
In an in vitro saphenous nerve skin preparation, all
subtypes of cutaneous neurons are present with myelinated
axons in normal numbers and a normal mechanical response
(Stucky et al. 2002). In dissociated culture from adult DRG
neurons, heat-induced inward currents have been recorded
from small-diameter neurons presumably corresponding to
364 Cell Tissue Res (2008) 333:353–371unmyelinated afferents. The percentage of IB4-binding
neurons with large heat-induced currents drops from 47%
in cultures from wildtype animals to 12% in those from
GFRalpha2 mutant mice (Stucky et al. 2002).
Thus,GFRalpha2mutantsrequiremoreanalysistoprovide
details regarding the alterations in afferent neuron physiology
and in TRP channel expression that may underlie the
behavioural phenotype. Comparison with mice having altered
neurturin expression should provide a clearer picture of the
role of neurturin and GFRalpha2 signalling in the differenti-
ation of the thermosensitive properties of DRG neurons.
Analysis in GFL-overexpressing mice
Overexpression of GDNF in mouse skin increases
mechanical sensitivity of C fibres
Overexpression of GDNF in transgenic mice under control of
the K14 keratin gene promoter results in a six-fold increase of
GDNF protein in skin (Zwick et al. 2002). DRG neuron
counts in adult L4/5 ganglia increase by 27% with a pre-
ferential effect on small ret-positive and IB4-binding neu-
rons. The number of ret-expressing cells increases from 40%
of DRG neurons in wildtype to 55% in transgenic animals
and IB4-binding cells increase from 33% in wildtype to 49%
in GDNF-overexpressing animals. In the saphenous nerve,
the number of myelinated axons increases by 26% and that
of unmyelinated axons by 72%. No change is observed in
the percentage of CGRP- or TRPV1-positive neurons and
the overlap with IB4 expression is also unaltered. In
transgenic skin, particularly the epidermis, the density of
PGP9.5-labelled fibres is increased. Central IB4-positive
projections are enhanced, whereas the thickness of CGRP
and TRPV1 bands in lamina 1 is unaltered. Behaviour to
noxious heat and to mechanical stimulation with von Frey
hairs is unaltered in GDNF-overexpressing mice (Zwick
et al. 2002). However, the mechanical sensitivity of C fibres
is affected.
Intracellular recording and labelling of DRG neurons in an
ex vivo preparation of spinal cord, DRG, nerves and
dorsolateral skin (Albers et al. 2006) shows 68% (11/16) of
C fibre soma to be IB4-positive in wildtype mice, whereas
all 20 cells recorded from GDNF-overexpressing animals are
IB4-positive. In wildtype animals, 25% (2/8) of the neurons
are CGRP-immunoreactive with no overlap to IB4-binding
cells, whereas 14% (1/7) of the IB4-positive cells recorded
from GDNF-overexpressing mice are also CGRP-positive.
No obvious difference is found in the central projection
pattern of individual afferents retrogradely labelled with
Neurobiotin. C fibre units in transgenic animals show no
difference in somal spike properties and resting membrane
potential but significantly faster conduction velocities. Impor-
tantly, mechanical thresholds are significantly decreased. All
of the C fibres with low-threshold mechanoreceptors (LTMR)
in transgenic back skin respond to noxious heat, whereas
LTMR in wildtype are not heat-responsive. This shows a
novel C fibre phenotype in GDNF-overexpressing mice.
Since their action potential duration is no different from
high-threshold mechanoreceptors (HTMR) and since C fibres
with LTMR are infrequent in wildtype back skin, they may be
derived from HTMR by lowering the mechanical threshold.
Analysis of the expression of putative mechanosensitive ion
channels by RT-PCR shows increased mRNA levels for acid-
sensitive ion channel 2a (ASIC2a) and ASIC2b but not for
ASIC1 and ASIC3 in GDNF-overexpressing animals. ASIC2
IR increases in small- but not large-diameter DRG neurons
and double-labelling shows the increase to occur preferential-
ly, but not exclusively, in IB4-binding cells (Albers et al.
2006). Of C fibres in wildtype back skin, 81% (21/26)
respond to noxious heat, whereas 97% (35/36) are heat-
sensitive in GDNF-overexpressing animals, heat threshold
and firing frequency however being unaltered. As all units
tested (n=5) are acid-sensitive, they are classified as
polymodal nociceptors. Ganglionic TRP channel mRNA
levels analysed by RT-PCR demonstrate a 1.5-fold increase
for the cold receptors TRPA1 and TRPM8, a 1.5-fold
decrease for the heat receptor TRPV1 and no change in
TRPV2, V3 and V4 when normalized against the house-
keeping gene D-glyceraldehyde-3-phosphate dehydrogenase.
Thus, the number of small ret-positive DRG neurons in-
creases in GDNF-overexpressing mice. In addition, the
mechanical thresholds of C fibre units decrease and ASIC2
expression is increased at the RNA and protein levels.
However, in behavioural tests, no mechanical hyperexcitabil-
ity is observed. Because of the six-fold increase of GDNF
protein in skin and the possible weak interaction of GDNF
with GFRalpha2 and 3 (for a review, see Airaksinen and
Saarma 2002) in addition to its signalling via GFRalpha1,
receptor crosstalk may be involved in these alterations. The
different effects of artemin overexpression (see below) make
it unlikely, however, that GFRalpha3 is significantly in-
volved in the effects of increased GDNF availability.
Artemin-overexpressing animals show increased C fibre
heat sensitivity
In transgenic mice overexpressing artemin under the control
of the K14 keratin gene promoter in skin, increased RNA and
protein levels are detected by RT-PCR and by immunolabel-
ling (Elitt et al. 2006). The neuron number in L4 DRG is
increased by 21% compared with wildtype, the percentage of
GFRalpha3-positive neurons being unchanged at 18% in
transgenic animals compared with 20% in wildtype. Norma-
lized mRNA levels for GFRalpha3, however, are increased
by 34%, indicating increased expression levels in positive
cells. Surprisingly, ret transcript levels are unchanged,
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shows no major change of innervation density and pattern in
skin. GFRalpha3- and TRPV1-immunoreactive fibres, how-
ever, are increased in number. Correspondingly, TRPV1 tran-
script levels are increased by 61% (RT-PCR), whereas
TRPV2, V3 and V4 transcripts are unchanged. The percent-
age of TRPV1-positive cells is no different in transgenic
animals (29% compared with 28% in wildtype) and overlap
with GFRalpha3 expression is nearly complete. Some 94% of
wildtype and 97% of transgenic GFRalpha3-positive cells are
TRPV1-immunoreactive (Elitt et al. 2006). TRPA1 is ex-
pressed by nearly all GFRalpha3- and TRPV1-positive
neurons. TRPA1 mRNA levels are increased by 210% (RT-
PCR) and IR in ganglion sections is more intense. Transcript
levels for ASIC1, 2a, 2b and 3 are decreased in female
transgenic mice and ASIC2a is decreased in males.
In an ex vivo preparation of skin, saphenous nerve, DRG
and spinal cord, the mechanical thresholds of C fibres and
mean firing rates after mechanical stimulation appear un-
changed. Heat thresholds are decreased, however, and firing
rates uponthermalstimulationare increased(Elittetal.2006).
Correspondingly, transgenic animals show no difference in
behavioural response to mechanical stimulation but an
increased heat and cold immersion response correlating with
increased TRPV1 and TRPA1 expression, respectively.
In vitro studies show that GDNF can regulate expression
of SP, voltage-gated sodium channels and TRPV1
In vitro studies on adult rodent DRG neurons show that
GDNF, similar to NGF, may affect the expression of neuro-
peptides and ion channels.
In dissociated rat DRG neurons grown for 1 week in
culture, GDNF increases SP levels as analysed by radioim-
munoassay (Skoff and Adler 2006). The percentage of
preprotachykinin mRNA-positive neurons and the number
of SP-immunoreactive cells are increased (Ogun-Muyiwa et
al. 1999). The effect is somewhat smaller than that caused by
NGF, with the addition of both NGF and GDNF having no
additive effects.
Expression of mRNAs for SNS and NaN voltage-
dependent sodium channels in cultures of DRG neurons is
restored by GDNF, whereas NGF is reported to rescue
downregulation of SNS, not NaN (Fjell et al. 1999c). GDNF
in contrast to NGF causes an increase in the peak amplitude
of the TTX-resistant sodium current in these cells.
The capsaicin response and TRPV1 expression is affected
by GFL growth factors in short-term and extended cultures.
Within minutes of application, GDNF, neurturin, artemin and
NGF potentiate the capsaicin response of mouse DRG
neurons as analysed by calcium imaging in short-term
(1 day) culture (Malin et al. 2006). Interestingly, GDNF
neither increases the percentage of heat-responsive neurons
nor the heat-induced current in culture (Stucky and Lewin
1999). In contrast, NGF increases the proportion of IB4-
positive and -negative neurons that repond to heat. In
corresponding cultures of adult rat DRG neurons, GDNF
increases capsaicin-induced cobalt uptake (Ogun-Muyiwa et
al. 1999;B r o ne ta l .2003). After extended culture periods
(1 week), TRPV1 mRNA levels are increased and a higher
number of positive cells is maintained (Ogun-Muyiwa et al.
1999). The GDNF-induced increase in TRPV1 IR in long-
term culture is similar to that affected by NGF (Bron et al.
2003). After inflammation induced by complete Freund
adjuvant, the percentage of trkA-positive and IB4-positive
cells that express TRPV1 increases in vivo (Amaya et al.
2004). The increase in the trkA-positive population can be
blocked by anti-NGF antibodies and that in the IB4-positive
population by anti-GDNF.
Thus, the culture studies strongly suggest that GDNF has
the potential to regulate directly the expression of neuropep-
tide and ion channel genes in DRG neurons. In vitro, GDNF
increases the proportion of neurons positive for SP and
TRPV1, markers for nociceptor subpopulations. The down-
regulation of TRPV1 by overexpression of GDNF in vivo
demonstrates, however, that regulatory processes in culture
cannot be easily extrapolated to the situation in situ.
Summary of analysis in DRG neurons
Expression of ret and GFRalpha receptor subunits
ret expression in mouse DRG is detectable as early as E11
in a small number of neurons. Although these cells are
trkB-positive, an increasing population of trkA-positive
cells expresses ret during the third embryonic week.
Postnatal loss of trkA in a subset of DRG neurons results
in the presence of a large population of small ret-positive,
IB4-positive and trkA-negative nociceptors in mature DRG.
In addition, a less-well-characterized population of large-
diameter ret-positive neurons exists.
The developmental onsetofGFRalpha receptorsubunitsin
DRG has not been analysed in detail. Low level expression is
detected at E13 and expression increases until birth and
postnatally. In the trigeminal ganglion of mouse embryos,
G F R a l p h a 1a n dG F R a l p h a 2m R N A sc a nb ed e t e c t e db yI S H
preceding ret expression (Luukko et al. 1997).
In adult rats, more than half of the ret-positive DRG cells
express GFRalpha1 and one third GFRalpha2. Another
third of ret-positive cells expresses GFRalpha3. The large
majority (>70%) of the GFRalpha3-positive cells express
trkA, CGRP and TRPV1 defining a peptidergic ret-positive
nociceptor population in contrast to the larger proportion of
non-peptidergic ret-positive nociceptors. The majority of
GFRalpha2-positive cells constitutes a population of small
non-peptidergic neurons.
366 Cell Tissue Res (2008) 333:353–371Effect on DRG neuron numbers
Even though GFLs have been isolated by means of their
survivaleffectsinvitro,celldeathisnotaprominentfeaturein
DRG of mutant mice in vivo. In ret mutants, no neuron loss is
reported from P14 DRG. Artemin and GFRalpha3 mutant
mice have adult DRG neuron counts no different from those
of wildtype animals, even though artemin-overexpressing
animals showa 20% increaseinneuronnumber.Forneurturin
and GFRalpha2 mutants, no DRG neuron counts are
available. Normal axon counts in the saphenous nerve of
GFRalpha2 mutants indicate that this signalling pathway may
not be important for DRG neuron survival either. Data on
neurturin-overexpressing mice are currently unavailable. For
newborn GDNF mutant animals, a loss of a quarter of the L5
DRG neurons is reported, which, however, is not observed in
GFRalpha1 mutants. In GDNF-overexpressing animals,
neuron number in L4/5 DRG increases by a quarter.
Effects of GFL signalling on afferent properties
GFL overexpression and GFRalpha mutation affect the
mechanical and thermal responsiveness of sensory neurons.
In the case of GDNF overexpression in skin, the mechanical
thresholds of C fibre afferents decrease, with LTMR showing
a heat responsiveness not observed in wildtype animals. In
artemin-overexpressing mice, heat thresholds of C fibre units
are reduced, whereas mechanical sensitivity appears unal-
tered. Neurturin may likewise affect heat-sensitivity since
heat-evoked currents are reduced in cultured small neurons
from GFRalpha2 mutant animals.
Regulation of channel expression
TRP channels are targets of GFL signalling. TRPA1 mRNA
expressionis abolished inret mutantDRG analysed atP14. In
miceoverexpressingGDNForartemin,TRPA1mRNAlevels
in DRG are increased and correlate with an increased cold
immersion response in artemin-overexpressing animals. Data
for neurturin-overexpressing mice are currently not available.
The picture is less consistent for TRPV1. Whereas TRPV1
expression is reduced in GDNF-overexpressing animals,
mRNA levels (but not the percentage of positive cells) are
increased in DRG of artemin-overexpressing mice. GDNF
application to cultured rat DRG neurons maintains elevated
expression levels. TRPV1 expression in ret mutant mice
appearsunaffected.Thus,forGDNF,adirectactiononTRPV1
expression seems possible, although its role in vivo is unclear.
For ASIC2 expression, a strong effect of GDNF over-
expression in vivo is observed and correlates with alterations
in mechanical sensitivity of C fibres. Whether this is attri-
butable to the direct regulation of ASIC expression remains to
be resolved.
Sensory phenotype specification
The recent results showing that mutation of the ret gene does
not alter the major subtype composition of DRG neurons and,
in particular, does not change the proportion of CGRP-
positive neurons in a major way suggest that ret signalling is
not essential for the gross segregation of DRG neuron
lineages. However, ret mutation compromises, but does not
prevent, the loss of trkA expression in a subset of DRG
neurons. In addition, ret mutation leads to a reduction of
GFRalpha1 and GFRalpha2, but not GFRalpha3, expression.
The results show that ret promotes the generation of trkA-
negative nociceptors and GFRalpha1- and GFRalpha2-
positive DRG neuron populations.
The effects of the ret mutation on TRP channel expression
reveal the regulation of subsets of genes expressed in
nociceptor populations. The expression of these channels is,
however, not restricted to either peptidergic or non-peptider-
gicnociceptors.ApproximatelyhalfoftheTRPV1-expressing
cells are trkA-positive and half express ret in rats. Mouse ret
mutants show unaltered TRPV1 expression, whereas TRPA1,
which is coexpressed with TRPV1 in rat, is lost from mutant
DRG. The observation suggests that ret signalling is not
required for the generation of a TRPV1-positive nociceptor
subclass but for the expression of an additional differentiation
marker, TRPA1.
The appearance of a novel class of heat-sensitive LTMR in
GDNF-overexpressing mice might be a modulation of
mechanical threshold in HTMR. The molecular nature of this
change is of interest since it may shed light on the possibility
of transition from HTMR to LTMR.
Conclusions and perspectives
ret and GFRalpha expression
ret expression is regulated differently during the development
of mouse sympathetic and sensory ganglia. Although initia-
tionofexpressioninDRGisfoundatE11.5inasmallnumber
of neurons that increases during embryonic and postnatal
development, all sympathetic neurons are positive at E11.5
and their proportion is downregulated to a subpopulation at
birth (Fig. 4 and compare Fig. 2 for E13.5 and P0).
The ret-positive neuron population entails cholinergic
neurons in sympathetic ganglia and non-peptidergic nocicep-
tors in DRG. The generation of the bulk of ret-positive cells in
DRG requires NGF signalling as shown in NGF/Bax double-
mutant mice. Only a small early ret-expressing population of
DRG neurons is NGF-independent. In sympathetic neurons, ret
expression is detected before trkA expression and appears
correlated with trkCexpression instead. The importance of trkC
signalling for ret expression in vivo remains to be determined.
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sensory and sympathetic neuron subpopulations whose
properties and target tissues are not fully defined. GFRal-
pha3-positive DRG neurons constitute a population of trkA
and ret-positive peptidergic afferents. Their generation seems
independent of ret and NGF signalling. In contrast, GFRal-
pha1- and GFRalpha2-positive DRG neurons depend on both
signalling pathways. GFRalpha1-expressing DRG neurons
are absent in newborn NGF/Bax mutant mice and GFRalpha2
expression is strongly reduced. Moreover, in ret mutant mice,
the expression of GFRalpha1 and GFRalpha2 is reduced in
DRG.These studies havebeentaken toindicatethatNGF and
ret signalling are involved in the initiation of expression and
later differentiation of the specific subpopulations, respective-
ly.However,asGFRalphaexpressionisinitiatedinthesecond
embryonic week, lack of GFRalpha expression in newborn
NGF/Bax mutant animals might not provide a reliable picture
of signalling requirements during initial differentiation. For
the cholinergic transmitter phenotype in sympathetic neurons,
a succession of differentiation stages with changing growth
factor requirements during embryonic development has been
shownwhere expressionisabsentfromgangliaofneonatalret
mutant mice but initiation of expression during embryogen-
esis is unaffected by the mutation.
Sympathetic transmitter phenotype
In sympathetic neurons of mammals and birds, noradrenergic
differentiationisinitiatedearlyduringneuronaldifferentiation
under the control of bone morphogenetic protein growth
factors (for reviews, see Ernsberger and Rohrer 1996;
Ernsberger 2000; Goridis and Rohrer 2002) and is followed
by cholinergic differentiation. The signals involved in the
induction of gene expression from the cholinergic locus
during the second embryonic week are not yet characterized.
After the ret-independent initial induction of ChAT and
VAChT expression in the majority or even all sympathetic
neurons, the cholinergic markers are lost in most cells and
become expressed at comparatively high levels in a small
subset of sympathetic neurons (Fig. 5). The segregation of
cholinergic gene expression to a neuronal subpopulation
occurs during the third embryonic week in mouse develop-
ment and ret signalling is indispensable for this process. In
newborn ret mutant animals, expression of ChAT and
VAChT is largely undetectable indicating that the down-
regulation of cholinergic gene expression has occurred but
that development of the remaining cholinergic neuron
population is disturbed. Available evidence suggests that
this is not attributable to cell loss but to altered marker ex-
pression. Whether ret signalling acts directly via the regula-
tion of gene expression or indirectly via the promotion of
neurite outgrowth and access to other cholinergic differenti-
ation signals remains to be resolved. Moreover, the ligands
involved in the observed effects have to be determined. The
postnatal increase in the number of cholinergic sympathetic
neurons depends on gp130 signalling (Stanke et al. 2006).
Whether ret signalling is also involved in the development of
cholinergic neurons postnatally needs to be clarified.
Afferent properties of DRG neurons
Sensory neurons in the DRG are characterized by differences
in mechanical, thermal and chemical responsiveness. Alter-
ations in the response to mechanical and thermal stimuli in
mice overexpressing GDNF and artemin demonstrate the
potential of these growth factors to tune sensory neuron
properties. In GDNF-overexpressing animals, mechanical
thresholds of C fibre units innervating skin are decreased
and a novel C fibre phenotype with low mechanical threshold
and response to noxious heat is observed. The mRNA levels
for the putative mechanosensitive ion channels ASIC2a and
2b are increased, whereas transcript levels for the heat
receptor TRPV1 are decreased. In artemin-overexpressing
animals, heat thresholds in cutaneous C fibres are lowered,
whereas mechanical thresholds are unaltered. TRPV1 tran-
script levels are increased in these animals but ASIC2
transcript levels are decreased. The observations demonstrate
that different properties within a sensory neuron population
can be regulated by different GFLs.
In ret mutant animals, TRPA1 expression is completely
absent at postnatal day 14, although TRPV1 and TRPM8
appear unaffected. Despite analysis at other stages being
pending, this observation indicates that ret signalling selec-
tively regulates a specific afferent feature. In mice over-
expressing GDNF or artemin, TRPA1 mRNA levels in DRG
are increased indicating that different GFLs regulate TRPA1
expression.
Perspectives
Observations on a variety of gene products involved in
specificneuronalfunctionshintatcrucialregulatoryprocesses
that occur during the third week in mouse embryogenesis and
that result in the development of sympathetic and sensory
neuron classes differing in molecular equipment and, conse-
quently, function. ret signalling is crucially involved in the
expression of the cholinergic markers ChAT and VAChT at
this time in sympathetic neurons. For TRPA1 expression in
DRG neurons, the analysis of the effect of ret mutation at
differentdevelopmentalstagesisrequiredtoshowthestageof
ret signalling involved in TRPA1 regulation. Comparison of
the different GFL and GFRalpha mutant mice is necessary to
specify the ligands active in vivo to induce cholinergic
properties in sympathetic neurons and TRP expression in
DRG neurons. Because of the prominent effect on neurite
outgrowth, the alterations in neuron differentiation observed
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secondary to altered neuritic growth and access to target-
derivedsignallingmolecules.Invitrostudiesontherespective
neuron populations should demonstrate whether the GFLs
identified in mutant analysis are capable of directly inducing
transmitter properties or ion channels.
These considerations indicate the possible interaction of
the different growth factor signalling pathways and the hier-
archical organization of the different growth factor families or
memberswithinonefamilyduringneuronaldifferentiation.In
sympathetic neurons, ret-dependent expression of cholinergic
properties during late embryogenesis is followed by the
gp130-dependent increase in the cholinergic neuron popula-
tionatpostnatalstages.However,whetherretsignallingisstill
required postnatally in cholinergic sympathetic neurons is not
clear. An analysis of whether such a succession of GFL and
cytokine signalling is relevant for DRG neuron differentiation
remains to be performed. In DRG neurons, a succession of
neurotrophin and GFL signalling regulates the differentiation
of nociceptor subpopulations. The acquisitionofret expression
in trkA-positive neurons during late embryogenesis requires
NGF, apart from its survival action, as shown in NGF/Bax
double-mutant mice. The postnatal downregulation of trkA in
these cells to form ret-positive trkA-negative non-peptidergic
nociceptors in turn requires ret. Whether a comparable process
operates during sympathetic neuron development seems
unlikely since sympathetic neurons retain trkA expression into
adulthood and widespread ganglionic ret expression precedes
trkA initiation (U. Ernsberger, review in preparation). Thus,
growth factor succession and interaction appears, at least in
part, specific to sympathetic versus sensory lineages.
The mutual regulation of neurotrophin and GFL signalling
pathways in the differentiation of non-peptidergic nociceptors
marks an important step forwards in deciphering the
hierarchical organization of regulatory pathways during the
extrinsic control of neuronal differentiation (for a review, see
Ibanez and Ernfors 2007). The finding that the transcription
factor Runx1 is crucially involved in this process unfolds
another essential issue. The proportion of trkA-positive DRG
neurons increases more than two-fold in Runx1 mutant mice
at the expense of ret-positive cells (Chen et al. 2006). This
shows that a Runx transcription factor is part of the
signalling pathways for regulating ret expression and in turn
prompts the question regarding the intracellular transduction
pathways mediating ret and GFL signalling.
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